<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Cilag Holding AG on the USD 2.3 billion cash tender offer for Crucell NV | Pestalozzi Attorneys at Law

Pestalozzi advised Cilag Holding AG on the USD 2.3 billion cash tender offer for Crucell NV

10.2010

Johnson & Johnson, through its affiliate Cilag Holding AG, and Crucell NV acquired all outstanding equity of Crucell that it does not already own. Crucell is a global biopharmaceutica company focused on the research & development, production and marketing of vaccines and antibodies against infectious disease worldwide. Pestalozzi acted as advisor to Johnson & Johnson and Cilag.

To the top